Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
BACKGROUND: Although it has long been appreciated that ovarian carcinoma subtypes (serous, clear cell, endometrioid, and mucinous) are associated with different natural histories, most ovarian carcinoma biomarker studies and current treatment protocols for women with this disease are not subtype spe...
Main Authors: | Martin Köbel, Steve E Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J Bowen, Diana N Ionescu, Ashish Rajput, Leah M Prentice, Dianne Miller, Jennifer Santos, Kenneth Swenerton, C Blake Gilks, David Huntsman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-12-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC2592352?pdf=render |
Similar Items
-
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
by: Mehl Erika, et al.
Published: (2007-11-01) -
Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
by: Wilko Weichert, et al.
Published: (2008-09-01) -
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
by: Swenerton Kenneth D, et al.
Published: (2009-12-01) -
Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
by: C. Blake Gilks
Published: (2010-01-01) -
Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation
by: Amy P. N. Skubitz, et al.
Published: (2011-02-01)